首页> 外文期刊>Trends in cancer. >The Hippo Pathway as a Driver of Select Human Cancers
【24h】

The Hippo Pathway as a Driver of Select Human Cancers

机译:作为精选人类癌的驱动器的河马路径

获取原文
获取原文并翻译 | 示例
       

摘要

The Hippo pathway regulates myriad biological processes in diverse species and is a key cancer signaling network in humans. Although Hippo has been linked to multiple aspects of cancer, its role in this disease is incompletely understood. Large-scale pan-cancer analyses of core Hippo pathway genes reveal that the pathway is mutated at a high frequency only in select human cancers, including malignant mesothelioma and meningioma. Hippo pathway deregulation is also enriched in squamous epithelial cancers. We discuss cancer-related functions of the Hippo pathway and potential explanations for the cancer-restricted mutation profile of core Hippo pathway genes. Greater understanding of Hippo pathway deregulation in cancers will be essential to guide the imminent use of Hippo-targeted therapies.
机译:河马途径调节多种物种中的无数生物学过程,是人类的关键癌症信号网络。 尽管河马与癌症的多个方面有关,但其在该疾病中的作用却尚不完全了解。 对核心河马途径基因的大规模泛癌分析表明,该途径仅在精选的人类癌症(包括恶性间皮瘤和脑膜瘤)中以高频突变。 河马途径放松管制也富含鳞状上皮癌。 我们讨论了河马途径与癌症相关的功能,并讨论了核心河马途径基因的癌症限制突变谱的潜在解释。 对癌症中河马途径放松管制的更多了解对于指导即将使用河马靶向疗法至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号